Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in …
JJ Cornelissen, WLJ Van Putten, LF Verdonck… - Blood, 2007 - ashpublications.org
Abstract The Dutch-Belgian Hemato-Oncology Cooperative Group and the Swiss Group for
Clinical Cancer Research (HOVON-SAKK) collaborative study group evaluated outcome of …
Clinical Cancer Research (HOVON-SAKK) collaborative study group evaluated outcome of …
Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
Y Wang, QF Liu, LP Xu, KY Liu… - Blood, The Journal …, 2015 - ashpublications.org
The effects of HLA-identical sibling donor (ISD) hematopoietic stem cell transplantation
(HSCT) on adults with intermediate-or high-risk acute myeloid leukemia (AML) in the first …
(HSCT) on adults with intermediate-or high-risk acute myeloid leukemia (AML) in the first …
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable …
V Gupta, MS Tallman, W He, BR Logan… - Blood, The Journal …, 2010 - ashpublications.org
We compared the outcomes of unrelated donor (URD, n= 358) with human leukocyte
antigen (HLA)–matched sibling donor (MSD, n= 226) transplantations in patients with acute …
antigen (HLA)–matched sibling donor (MSD, n= 226) transplantations in patients with acute …
Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia
W Saber, S Opie, JD Rizzo, MJ Zhang… - Blood, The Journal …, 2012 - ashpublications.org
Approximately one-third of patients with an indication for hematopoietic cell transplantation
(HCT) have an HLA-matched related donor (MRD) available to them. For the remaining …
(HCT) have an HLA-matched related donor (MRD) available to them. For the remaining …
Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk …
RF Schlenk, K Döhner, S Mack, M Stoppel… - Journal of Clinical …, 2010 - ascopubs.org
Purpose To assess the impact of allogeneic hematopoietic stem-cell transplantation (HSCT)
from matched related donors (MRDs) and matched unrelated donors (MUDs) on outcome in …
from matched related donors (MRDs) and matched unrelated donors (MUDs) on outcome in …
Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first …
S Yu, F Huang, Y Wang, Y Xu, T Yang, Z Fan, R Lin… - Leukemia, 2020 - nature.com
This study aimed to investigate graft-versus-leukemia (GVL) of haploidentical donor (HID)
compared with HLA-matched sibling donor (MSD) for high-risk acute myeloid leukemia (H …
compared with HLA-matched sibling donor (MSD) for high-risk acute myeloid leukemia (H …
Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns
V Gupta, MS Tallman… - Blood, The Journal of the …, 2011 - ashpublications.org
Progress in the last decade has improved the understanding of leukemia biology. Molecular
markers in combinations with cytogenetics have improved the risk stratification of acute …
markers in combinations with cytogenetics have improved the risk stratification of acute …
[HTML][HTML] Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative …
A Shimoni, M Labopin, B Savani, L Volin… - Journal of hematology & …, 2016 - Springer
Background Myeloablative (MAC) and reduced-intensity conditioning (RIC) are established
approaches for allogeneic stem cell transplantation (SCT) in acute myeloid leukemia (AML) …
approaches for allogeneic stem cell transplantation (SCT) in acute myeloid leukemia (AML) …
Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a …
J Schetelig, M Bornhäuser, C Schmid… - Journal of Clinical …, 2008 - ascopubs.org
Purpose In patients with acute myeloid leukemia (AML), differential indications for matched
sibling and unrelated hematopoietic stem-cell transplantation (HCT) are considered, and …
sibling and unrelated hematopoietic stem-cell transplantation (HCT) are considered, and …
Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete …
S Suciu, F Mandelli, T de Witte, R Zittoun, E Gallo… - Blood, 2003 - ashpublications.org
Abstract In the European Organization for Research and Treatment of Cancer Leukemia
Group and Gruppo Italiano Malattie Ematologiche dell'Adulto (EORTC-LG/GIMEMA) acute …
Group and Gruppo Italiano Malattie Ematologiche dell'Adulto (EORTC-LG/GIMEMA) acute …